Blog/

New Aimedis services to launch in Q3-2019

By |2019-04-19T13:21:44+02:00März 11th, 2019|News|

We are happy to announce, that we have closed a new partnership in the area of quality management services for hospitals and doctors. This will lead to 2 new modules that will be launched already in Q3-2019 and will generate a big benefit for patients, doctors and healthcare institutions. Please stay tuned for further information soon to be disclosed.

Second Opinion portal for cardiology now open

By |2019-02-22T23:23:37+01:00Februar 22nd, 2019|Unkategorisiert|

Aimedis is happy to announce that our second opinion portal including videochat with cardiologists is publicly available now. We will open the Aimedis ecosystem to the public step by step to offer you the latest eHealth applications on a device of your choice.

You can reach the second opinion portal via clicking the following link:

In case you are searching for support, please drop us a message to secondopinion@aimedis.com.

You can also send your documents to this email, which in the next step can be stored in Aimedis at your discretion.

 

Your Aimedis team

 

Second Opinion portal for cardiology now open

By |2019-02-07T19:27:31+01:00Februar 7th, 2019|BREAKING NEWS, Platform|

Aimedis is happy to announce that our second opinion portal including videochat with cardiologists is publicly available now. We will open the Aimedis ecosystem to the public step by step to offer you the latest eHealth applications on a device of your choice.

You can reach the second opinion portal via clicking the following link:

In case you are searching for support, please drop us a message to secondopinion@aimedis.com.

You can also send your documents to this email, which in the next step can be stored in Aimedis at your discretion.

 

Your Aimedis team

 

Aimedis ICO Presale finished – Token to be sent to the presale participants in the next 2 weeks

By |2019-02-04T12:37:18+01:00Februar 3rd, 2019|News|

Dear supporters, token buyers and friends. We are looking back at a very moving and intersting time in the crypto space in the last months. Aimedis thanks all of you who help Aimedis realize the vision of a unique medical ecosystem that will change the way people communicate and handle their health data and the way they communicate with their doctors and medical institutions.

Aimedis has finished the presale in November 2018 and has postponed the main sale of the Aimedis tokens until the market has recovered. The team has also discussed listing the token directly after the presale but we decided not to do that to protect all the people
who bought the token in the presale and the company as many examples showed a massive decrease in value for tokens listed in the bear market due to low market volumes.

So please stand by for Aimedis next steps, we will update you about the upcoming main sale and the listing process of AIM tokens on several exchanges.

All you tokens buyers that bought the token in the presale watch out for your wallets in the upcoming 2 weeks.

For any questions, concerns or ideas, please contact us any time via contact@aimedis.com.

We wish each and everyone of you a successful year 2019 in the crypto market and together with us.

 

Your Aimedis team

End of Presale and the Start of a New Adventure: Happy Holidays

By |2018-12-23T16:38:30+01:00Dezember 23rd, 2018|General, ICO, Platform|

2018 has literally been a rollercoaster for Aimedis. Conferences, pitches, events, teamwork to make the dream work. We would like to thank each and every one of you who contributed to where we are today: a running product, in use across 20 hospitals in 4 countries (Europe and Asia).

Presale has ended a few weeks ago, as we announced on our social media channels and in our Telegram community.  We have learned valuable lessons, especially with the crypto market crash. There is no date set for the crowd sale yet.

Thoughts of 2019…

Christmas and New Year’s are a great time to step away from the daily habits and just indulge yourself in quality time with family, friends, loved ones.

To be grateful, and to cherish what the past 12 months have given you. To celebrate and to look forward to the new year. The team will take a break to recharge and prepare for the upcoming steps in our roadmap.

aimedis

For 2019, we’d like to focus on the development of Aimedis 2.0 and AIMchain, and bring the product and its functionalities into more hospitals, to serve our patients, doctors, and partners (insurance, pharma companies).

Enjoy the winter holidays, wherever you are in the world.

Peace and love,

Roxana

CCO @ Aimedis

Dementia – Developments In Care

By |2018-10-03T22:18:14+02:00Oktober 3rd, 2018|AI in news, News|

 

New developments in Healthtech are happening all the time. Here is one which has hit the news headlines recently that really sounds very interesting.

 

Dementia Research

Researchers at a Japanese University have developed an AI system that can help to diagnose dementia.

The system that they have devised is able to detect the very early signs, much earlier than traditional methods. This means that patients can be made aware of potential problems very early on. Giving them more time to take  full advantage of treatment options, and so have a better long term outcome.

 

Currently, diagnosing dementia can be time consuming, expensive and distressing for patients. Traditional scans are used in conjunction with cognitive function tests, to check the function of the brain.

A global ageing population means that now more people are developing dementia, so there is a real need for quick, effective diagnosis that can lead to an earlier intervention.

New Developments

A group of researchers who are based at Osaka University and The NARA Institute of Science and Technology have discovered that it is indeed possible to detect the very early signs of dementia . And that  it is possible to do this with AI, quickly, effectively and in a non invasive manner. This helps patients save time, money and more importantly have a much less stressful experience.

 

This  technique uses machine learning in such a way that it is possible to study the way that elderly people speak when answering simple questions from a computer avatar.

The AI system is able to create a dialogue with elderly patients. It then records  their speech patterns, language, and faces. From this information it is then able to complete an evaluation from analyzing gaze, response times,  intonation, and language used.

After just six questions, the AI system was able to identify which patients in a control group did suffer from dementia, with a success rate of over 90%.

 

Future Potential

The senior research author Takashi Kudo said, “If this technology is further developed, it will become possible to know whether or not an elderly individual is in the early stages of dementia through conversations with computer avatars at home on a daily basis. It will encourage them to seek medical help, leading to early diagnosis.”

 

One of the main advantages here, is that not only is the success rate of the test already high, with a potential for early and accurate diagnosis,  it can be a test which is very easily conducted at home. There is no need to visit any medical center, or Doctors office. This convenience can only be a positive thing – often travelling  can be a factor in determining whether an elderly patient feels well or confident enough to undergo traditional methods of testing.

 

This is an excellent example of how advances in the health tech industry mean  that healthcare is now becoming much more accessible. And more importantly, here is a major improvement in diagnosis and treatments for a whole range of issues. Patient care with regards to dementia is one of these areas which can benefit hugely.